Jim Hoyes has a long track record of creating strategies and driving exceptional performance in the life sciences sector. In addition to providing advisory services to clients, Jim focuses on corporate development initiatives in the life sciences sector and the implementation of key strategic initiatives designed to scale up the firm’s global operations. Jim has deep expertise in all areas of corporate development and commercialization of pharmaceutical and biotechnology products. He has led a number of financial transactions including licensing and M&A deals.
Prior to joining RxC International, Jim served as President of EMD Serono, leading the company in consistent double-digit revenue gains. Prior to EMD Serono, he held leadership positions with several leading biopharma companies, including chief commercial officer at Serono, vice president of Marketing at Elan, and vice president of Managed Markets at Sanofi.
Jim is on the board of MassBIO and has served on the boards of PhRMA and BIO. Jim is also involved with the boards of several non-profit community service organizations in the greater Boston area. Jim received a B.S. in Biology from Penn State University.